Apelin/APJ system: A novel therapeutic target for locomotor system diseases

被引:11
|
作者
Luo, Jingshun [1 ]
Liu, Wei [2 ]
Feng, Fen [3 ]
Chen, Linxi [1 ]
机构
[1] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hunan Prov Key Lab Tumor Microenvironm Respons Dr, Inst Pharm & Pharmacol, Hengyang 421001, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Dept Pharm, Changsha 410013, Peoples R China
[3] Shaoyang Univ, Sch Med, Shaoyang 422000, Peoples R China
基金
中国国家自然科学基金;
关键词
Apelin; APJ system; Locomotor system; Metabolism; Osteoarthritis; Osteoporosis; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; MESENCHYMAL STEM-CELLS; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ENDOGENOUS LIGAND; AEROBIC EXERCISE; RECEPTOR; APJ;
D O I
10.1016/j.ejphar.2021.174286
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apelin is an endogenous ligand of G protein-coupled receptor APJ. Apelin/APJ system is widely expressed in abundant tissues, especially bone, joint and muscle tissue. This review focus on the effects of apelin/APJ system on locomotor system. An increasing number of evidence suggests that apelin/APJ system plays a crucial role in many physiological and pathological processes of locomotor system. Physiologically, apelin/APJ system promotes bone formation, muscle metabolism and skeletal muscle production. Pathologically, apelin/APJ system exacerbates osteoarthritis pathogenesis, whereas it alleviates osteoporosis. Besides, the level of apelin expression is regulated by different training modes, including continuous aerobic exercise, high-intensity interval training and resistance exercises. More importantly, exercise-induced apelin may be a potent pharmacological agent for the treatment of diseases and the regulation of physiological processes. Considering the pleiotropic effects of apelin on locomotor system, apelin/APJ system may be an important therapeutic target for locomotor system diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Apelin/APJ system and kidney disease
    HUANG Zhen
    CHEN Zhe
    HU Hao-liang
    LIU Jia-qi
    ZHOU Hong
    WU Le-le
    HUANG Shi-fang
    LI Lan-fang
    CHEN Lin-xi
    中国药理学与毒理学杂志, 2016, (10) : 1056 - 1056
  • [32] The Apelin/APJ System in Psychosis and Neuropathy
    Lv, Shuang-Yu
    Chen, Wei-Dong
    Wang, Yan-Dong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [33] Neuroprotective gain of Apelin/APJ system
    Zhou, Jia-Xiu
    Shuai, Nian-Nian
    Wang, Bo
    Jin, Xin
    Kuang, Xin
    Tian, Shao-Wen
    NEUROPEPTIDES, 2021, 87
  • [34] The apelin-APJ system in heart failure pathophysiologic relevance and therapeutic potential
    Japp, Alan G.
    Newby, David E.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (10) : 1882 - 1892
  • [35] Expanding role for the apelin/APJ system in physiopathology
    Carpene, C.
    Dray, C.
    Attane, C.
    Valet, P.
    Portillo, M. P.
    Churruca, I.
    Milagro, F. I.
    Castan-Laure, I.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2007, 63 (04) : 359 - 373
  • [36] Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential
    Pang, Bo
    Jiang, Yin-Ru
    Xu, Jia-Yao
    Shao, Dong-Xue
    Hao, Li-Ying
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 949
  • [37] The Role of Apelin-APJ System in Diabetes and Obesity
    Li, Cheng
    Cheng, Hongna
    Adhikari, Binay Kumar
    Wang, Shudong
    Yang, Na
    Liu, Wenyun
    Sun, Jian
    Wang, Yonggang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] The Role of the Apelin/APJ System in the Regulation of Liver Disease
    Lv, Xinrui
    Kong, Jing
    Chen, Wei-Dong
    Wang, Yan-Dong
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [40] THE APELIN/APJ SYSTEM LINKS ANGIOGENESIS TO LIVER FIBROSIS
    Oesterreicher, C.
    Schramek, D.
    Penz-Oesterreicher, M.
    Kuba, K.
    Penninger, J. M.
    Brenner, D.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S416 - S416